Literature DB >> 19726516

Contribution of matrix, fusion, hemagglutinin, and large protein genes of the CAM-70 measles virus vaccine strain to efficient growth in chicken embryonic fibroblasts.

Luna Bhatta Sharma1, Shinji Ohgimoto, Seiichi Kato, Sekiko Kurazono, Minoru Ayata, Kaoru Takeuchi, Toshiaki Ihara, Hisashi Ogura.   

Abstract

Attenuated live vaccines of measles virus (MV) have been developed from clinical isolates by serial propagation in heterologous cells, mainly chicken embryonic cells. The safety and effectiveness of these vaccines have been well established. However, the molecular mechanism of their attenuation remains a subject of investigation. The CAM-70 MV vaccine strain was developed from the Tanabe strain by serial propagation in chicken embryonic cells. In the present study, we assessed the contribution of each gene in the CAM-70 strain to efficient growth in chicken embryonic fibroblasts (CEF). We used a cloned MV IC323 based on the wild-type IC-B strain and generated a series of IC323s that possess one or more of the CAM-70 genes. Then, we examined the infection of CEF and CEF expressing human signaling lymphocyte activation molecule with the recombinant MVs. Our results demonstrated that MV needs to adapt to CEF at both the entry and postentry steps and that the CAM-70 matrix protein gene plays an important role in adaptation to CEF at the early stage of the virus replication cycle. The CAM-70 large protein gene was responsible for the efficient transcription and replication in CEF, and the CAM-70 hemagglutinin and fusion protein genes were responsible for efficient entry. Investigations focusing on these genes might elucidate unknown molecular mechanisms underlying the attenuation of MV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726516      PMCID: PMC2772719          DOI: 10.1128/JVI.01110-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Clinical and serological studies on CAM-70 live attenuated measles vaccine: an 18-year survey at a pediatric clinic in Japan.

Authors:  Takao Ozaki; Yoshiharu Matsui; Yuji Kajita; Naoko Nishimura
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

3.  Studies on further attenuated live measles vaccine. II. Correlation between the titer of the vaccine, the antibody response and clinical reactions.

Authors:  S Ueda; M Takahashi; Y Minekawa; T Ogino; N Suzuki
Journal:  Biken J       Date:  1970-06

4.  CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition.

Authors:  C Erlenhoefer; W J Wurzer; S Löffler; S Schneider-Schaulies; V ter Meulen; J Schneider-Schaulies
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus.

Authors:  E C Hsu; C Iorio; F Sarangi; A A Khine; C D Richardson
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

6.  Recovery of pathogenic measles virus from cloned cDNA.

Authors:  M Takeda; K Takeuchi; N Miyajima; F Kobune; Y Ami; N Nagata; Y Suzaki; Y Nagai; M Tashiro
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 7.  Measles virus receptor SLAM (CD150).

Authors:  Yusuke Yanagi; Nobuyuki Ono; Hironobu Tatsuo; Koji Hashimoto; Hiroko Minagawa
Journal:  Virology       Date:  2002-08-01       Impact factor: 3.616

8.  Reduced ability of hemagglutinin of the CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM.

Authors:  Seiichi Kato; Shinji Ohgimoto; Luna Bhatta Sharma; Sekiko Kurazono; Minoru Ayata; Katsuhiro Komase; Makoto Takeda; Kaoru Takeuchi; Toshiaki Ihara; Hisashi Ogura
Journal:  Vaccine       Date:  2009-04-23       Impact factor: 3.641

9.  Studies on further attenuated live measles vaccine. I. Adaptation of measles virus to the chorioallantoic membrane of chick embryo and clinical tests on the strain.

Authors:  S Ueda; M Takahashi; Y Minekawa; T Ogino; N Suzuki
Journal:  Biken J       Date:  1970-06

10.  Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay.

Authors:  Bettina Bankamp; Sean P Kearney; Xin Liu; William J Bellini; Paul A Rota
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more
  4 in total

Review 1.  Measles Vaccine.

Authors:  Diane E Griffin
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

2.  Nipah Virus Matrix Protein Influences Fusogenicity and Is Essential for Particle Infectivity and Stability.

Authors:  Erik Dietzel; Larissa Kolesnikova; Bevan Sawatsky; Anja Heiner; Michael Weis; Gary P Kobinger; Stephan Becker; Veronika von Messling; Andrea Maisner
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

Review 3.  Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines.

Authors:  Aileen Ebenig; Mona V Lange; Michael D Mühlebach
Journal:  NPJ Vaccines       Date:  2022-10-15       Impact factor: 9.399

Review 4.  Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises.

Authors:  Aoife K O'Connell; Florian Douam
Journal:  Vaccines (Basel)       Date:  2020-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.